Tradestie Institutional Equity Comparison Engine

LCTX vs MTNB โ€” Head-to-Head Terminal

6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.

Market Close: 2026-11-19 Buy Verdict Report Ask Alpha

Pillar 1 Executive Scorecard & Category Winner Tally

LCTX Overall Edge

LCTX Captures Institutional Edge (2โ€“2 Pillars ยท 8โ€“2 Matrix Metrics)

Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Lineage Cell Therapeutics, Inc. (LCTX) driven by superior Valuation, Growth & Margin while MTNB counters with relative strength in Momentum & Technical, Options & Structure. Fundamentally, LCTX trades at 30.7x Forward P/E with -280.3% operating margin (-61.0% YoY revenue) versus MTNB at N/M Forward P/E and 0.0% operating margin (-100.0% YoY). In options structure, LCTX sits in BREAKDOWN (100th %ile IV; Dealer Gamma Walls on Pro) against MTNB sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro).

Valuation Winner LCTX
LCTX 30.7x vs MTNB N/M Fwd P/E
Growth & Margin Winner LCTX
Op Margin -280.3% vs 0.0% ยท YoY -61.0% vs -100.0%
Momentum & Technical Winner MTNB
1Y -53.7% vs -31.4% ยท 52W Pos 4% vs 22%
Options & Structure Winner MTNB
BREAKDOWN (100th %ile IV) vs UNCLASSIFIED (N/A IV)
LCTX NYSE American
Lineage Cell Therapeutics, Inc.
Biological Products, (No Disgnostic Substances)
$0.82
-2.21% 1D
Market Cap $212.1M
1M Return -13.82%
1Y Return -53.67%
Forward P/E 30.7x
Unified AI Score
58.9 / 100 HOLD
Tech 65.0 Fund 54.0 Flow 65.0 Mom 45.0
MTNB NYSE American
Matinas BioPharma Holdings, Inc.
Pharmaceutical Preparations
$0.81
-10.98% 1D
Market Cap $979,904
1M Return -46.7%
1Y Return -31.35%
Forward P/E N/M
Unified AI Score
54.6 / 100 HOLD
Tech 53.0 Fund 58.0 Flow 50.0 Mom 60.0

Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)

1Y Indexed Return: LCTX -53.67% MTNB -31.35% Spread: +22.32 pp (MTNB Lead)

Pillar 3 Multi-Year Annual Revenue & Operating Margin Trajectory (USD)

Split-Invariant Revenue ($B) & Operating Margin (%)
Period LCTX Revenue MTNB Revenue LCTX Op. Margin MTNB Op. Margin Margin Edge
FY2018 $0M $0M -837.9% -12230.9% LCTX
FY2019 $0M $0M -1106.0% -21067.4% LCTX
FY2020 $0M $0M -1448.4% -15288.4% LCTX
FY2021 $0M $0M -1133.6% -74954.5% LCTX
FY2022 $10M $0M -153.2% -771.3% LCTX
FY2023 $10M $0M -276.5% -2168.4% LCTX
FY2024 $10M N/A -226.1% N/A LCTX
FY2025 $10M N/A -251.6% N/A LCTX

Pillar 4 Head-to-Head Fundamental & Valuation Matrix

Matrix Tally: LCTX (8) vs MTNB (2)
Institutional Metric LCTX MTNB Criterion Row Winner
Market Capitalization Scale $212.1M $979,904 Larger Scale LCTX
Trailing P/E Ratio Valuation 30.7x N/M Lower Multiple LCTX
Forward P/E Ratio Valuation 30.7x N/M Lower Multiple LCTX
Revenue Growth (YoY) Growth -61.0% -100.0% Higher Growth LCTX
Operating Margin (TTM) Profitability -280.3% 0.0% Higher Margin MTNB
Net Profit Margin Profitability 16.2% 0.0% Higher Margin LCTX
Return on Equity (ROE) Capital Efficiency 4.3% -147.5% Higher ROE LCTX
52-Week Range Position Momentum 4% ($1โ€“$2) 22% ($0โ€“$3) Stronger Trend MTNB
Beta / 30D Volatility Risk Regime 1.36ฮฒ ยท 79% Vol -7.20ฮฒ ยท 147% Vol Lower Realized Risk LCTX
Unified Institutional Score Composite Signal 58.9 / 100 (HOLD) 54.6 / 100 (HOLD) Higher Composite LCTX

Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor

Full LCTX vs MTNB Buy Guide
LCTX BREAKDOWN
6d in phase ยท OBV DISTRIBUTION
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 100th %ile
IV Regime Extreme (>80th %ile)
Live LCTX Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →
MTNB UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile N/A
IV Regime Unclassified
Live MTNB Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →

Pillar 6 90-Day Technical & R&D Innovation Disclosures

Corporate R&D & Foundry Tracker
Neither LCTX nor MTNB registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.